Skip to content

SRAE With Embospheres for Hemorrhoids.

Superior Rectal Artery Embolization With Tri-acryl Gelatin Particles for Treatment of Symptomatic Hemorrhoids: Safety and Efficacy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03740321
Enrollment
50
Registered
2018-11-14
Start date
2018-12-01
Completion date
2020-12-01
Last updated
2018-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Embolization, Hemorrhoids

Keywords

Hemorrhoids, Superior rectal artery, embolization, microspheric particles

Brief summary

In this study , safety and efficacy of superior rectal artery embolization with embospheres will be researched prospectively.

Detailed description

Symptomatic hemorrhoidal disease is a still important public health problem although there are many surgical and nonsurgical minimal invasive treatment methods. Treatment methods are not satisfactory or invasive in some percent of the patients. Superior rectal artery embolization(SRAE) for hemorrhoids is an adapted technique derived from Doppler-guided hemorrhoidal artery ligation (DGHAL). In this technique, the distal branches of the superior rectal artery arising from the inferior mesenteric artery is occluded endovascularly with coils. Its feasibility and safety were supported by articles. Collateralization and recurrence was seen following coil embolization. To prevent this , tri-acryl gelatin microspheres in 500-700 and 700-900 micrometers in size will be used. Safety and efficacy of embolization and using different sized particles will be evaluated.

Interventions

DEVICEEmbolization with tri-acryl gelatin (Embosphere) particles

Left, right and posterior branches of superior rectal artery will be embolized with tri-acryl gelatin particles in 500-700 and 700-900 micrometers in size until homeostasis will be achieved.

Sponsors

Eskisehir Osmangazi University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Intervention model description

Blocked randomized, single blind, prospective study

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients with symptoms of hemorrhoidal disease * Patients with written informed consent * Patients refusing surgery or other interventional methods * Patients with high risk for surgery * Patients accepting follow ups

Exclusion criteria

* Previous intervention * Colorectal diseases other than hemorrhoids * Patients with anal stenosis * Patients with rectal prolapsus * pregnant patients * Patients with contraindications for technical steps or contrast usage. * Patients do nor or could not give written informed consent

Design outcomes

Primary

MeasureTime frameDescription
Incidence of procedure related mortality (safety)12 monthThe mortality rate among the patients during 12 months related with interventional procedure.
Incidence of procedure related complications (safety)12 monthThe morbidity rate among the patients during 12 months related with interventional procedure.
Incidence of the patients' being free of symptoms from hemorrhoidal disease (efficacy)12 monthThe efficacy and clinical success of the procedure will be evaluated

Secondary

MeasureTime frameDescription
Technical successOn the day of interventionThe rate of interventions that were performed successfully.
Recurrence3-6-12. monthsRecanalization or collateralization of the previously embolized rectal arteries.

Countries

Turkey (Türkiye)

Contacts

Primary ContactFahrettin Kucukay, Prof.
fkucukay@hotmail.com+905325875318

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026